Ribosomal protein L9 pseudogene 14 (RPL9P14)

Ribosomal protein L9 pseudogene 14 (RPL9P14) is a noncoding pseudogene originating from the ribosomal protein L9 gene. Unlike protein-coding genes, pseudogenes do not produce a functional protein product. RPL9P14 does not have a known biological function or direct association with disease and is not the subject of drug targeting or biomarker development. Its designation as a pseudogene reflects its origin as a remnant or sequence duplication of a functional gene, typically without transcriptional or translational activity[2][3]. The term “pseudogene” refers to genomic DNA sequences similar to normal genes but nonfunctional; they are usually the result of gene duplication or retrotransposition. In the case of ribosomal protein genes like RPL9, there are many pseudogenes dispersed throughout the human genome[5][6]. The functional RPL9 gene encodes an essential component of the 60S ribosomal subunit, with roles in protein synthesis and, in some contexts, disease (e.g., Diamond-Blackfan Anemia), but this does not apply to RPL9P14[5][6]. No evidence in public gene or protein databases suggests that RPL9P14 is a therapeutic target, has biological activity, or is involved in diseases or drug action[2][3][6].

Other names

RPL9_3_318RPL9P14[2][3]

null